Q3 2019 Bristol-Myers Squibb Co Earnings Call Transcript
Good day, everyone, and welcome to the Bristol-Myers Squibb 2019 Third Quarter Results Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference to Mr. John Elicker, Senior Vice President, Public Affairs and Investor Relations. Please go ahead, sir.
Thanks, Augusta, and good morning, everybody. We're here to discuss our Q3 earnings results. With me, we have Giovanni Caforio, our Chairman and Chief Executive Officer; Charlie Bancroft, our Chief Financial Officer, who'll both have prepared remarks; Chris Boerner, Chief Commercialization Officer; and Dr. Samit Hirawat, Chief Medical Officer and Head of Drug Development, will be here for Q&A as well.
I'll handle the legal requirements. First, during the call, we'll make statements about the company's future plans and prospects that constitute forward-looking statements. Actual results may differ materially. From those indicated by these forward-looking statements as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
